Quick Takeaways
- Robert Michael Dudley has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $91,934.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Robert Michael Dudley
- Location
- Boston, MA
- Summary
- The estimated net worth of Robert Michael Dudley is at least $91,934 dollars as of 02 Oct 2023. Robert Michael Dudley is the Chief Executive Officer, Director of Transcode Therapeutics, Inc. and owns shares of Transcode Therapeutics, Inc. (RNAZ) stock worth about $91.9K.
- Signature
- /s/ Thomas A. Fitzgerald, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert Michael Dudley and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Transcode Therapeutics, Inc. ($91,934).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robert Michael Dudley
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | Chief Executive Officer, Director | $91,934 | 28 Sep 2023 |
Insider Transactions Reported by Robert Michael Dudley:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.